Brief: Amniotics Q3 EBITDA Loss Widens To 9.8 Mln

Amniotics AB (publ)

12/11/2021 07:28

Nov 12 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * INTERIM REPORT, 3RD QUARTER 2021
    * Q3 OPERATING PROFIT (EBITDA): SEK -9,778 (-5,437) THOUSAND
    * Q3 RESULT FOR PERIOD: SEK -10,211 (-5,998) THOUSAND
    * IN AMNIOTICS ONGOING PRE-CLINICAL PROGRAM IN PEDIATRIC
NEUROLOGY
INDICATION, WE EXPECT DATA OUTCOME IN Q4 THIS YEAR AND WE EXPECT
TO PRESENT THIS IN 2022

Source text for Eikon:  ID:nMFN2cqxXz 
Further company coverage:  AMNI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))